BIIB068 is a Selective, Reversible and Orally Active BTK Inhibitor
In this article, we will introduce a selective, reversible, and orally active BTK inhibitor, BIIB068. As a selective inhibitor, BIIB068 exhibits an IC50 of 1 nM and a Kd of 0.3 nM against BTK.…